Supplements for Skin: Collagen, Vitamin C and What Else Works

Oral Collagen Peptides

The mechanistic objection is fair: collagen is a protein, digestion breaks it into amino acids, and the body does not route dietary collagen to skin. The counterargument is that specific di- and tripeptides, particularly prolyl-hydroxyproline, survive digestion, appear in plasma and may signal to fibroblasts rather than serving only as substrate.

The trial picture. Multiple small randomised trials report improvements in skin hydration and elasticity, with some reporting reduced wrinkle depth, using instrumental measures over 8 to 12 weeks. Meta-analyses of these trials report positive pooled effects. Doses are typically 2.5 to 10 g daily of hydrolysed peptides.

The caveats that matter. Many trials are industry-funded, sample sizes are small, effect sizes are modest, and duration is short. Different products use different peptide profiles, so results may not transfer between them. And whether effects persist after stopping is largely unstudied.

The honest assessment. Better evidence than most skin supplements, weaker than a topical retinoid, and a reasonable purchase for someone who wants it with realistic expectations. It also has plausible Pillar 7 benefits alongside loading, which improves the case for the same expenditure.

Vitamin C, Topical and Oral

Vitamin C is a required cofactor for the prolyl and lysyl hydroxylases that stabilise collagen, so it is genuinely necessary for collagen synthesis rather than incidentally associated.

Oral. Correcting a shortfall matters, and supplementing beyond adequacy has limited evidence for skin outcomes. Severe shortfall causes scurvy, in which collagen synthesis fails, which demonstrates necessity rather than a dose-response benefit above adequacy.

Topical. This is where the useful evidence sits. L-ascorbic acid at 10 to 20 per cent in an appropriately formulated low-pH vehicle has trial support for antioxidant protection, some collagen stimulation and reduction of pigmentation. It is notoriously unstable, oxidising on exposure to light, air and water, and a product that has turned yellow or brown has degraded.

Formulation matters more than concentration. Derivatives such as sodium ascorbyl phosphate and magnesium ascorbyl phosphate are more stable and require conversion, with generally weaker evidence than L-ascorbic acid.

With collagen peptides, vitamin C adequacy is a sensible pairing since it is required for the synthesis the peptides aim to support.

The Rest of the Category

Two entries deserve highlighting. Oral nicotinamide has trial evidence for reducing new non-melanoma skin cancers in people with a history of them, which is a hard outcome rather than a cosmetic measure and among the more interesting findings in dermatological supplementation. And biotin is worth naming as the clearest example of a heavily marketed compound with essentially no evidence in people whose status is adequate, with the added problem that it interferes with thyroid and troponin assays and has caused clinical confusion.

The Topicals That Outperform Every Supplement

Since the question is skin outcomes rather than supplement outcomes, the comparison is worth making explicit.

Sunscreen. The best-evidenced skin intervention of any kind, with trial evidence for reducing photoageing and skin cancer incidence. Broad-spectrum, applied daily, reapplied when exposure continues.

Topical retinoids. Tretinoin has the strongest evidence for improving photoaged skin, with histological evidence of increased collagen alongside appearance measures. Retinol and retinaldehyde are weaker over-the-counter alternatives. Irritation and photosensitivity are dose-limiting, and gradual introduction is the practical approach.

Topical vitamin C, as above.

Topical niacinamide. Reasonable evidence for barrier function, pigmentation and sebum, and well tolerated.

Emollients and barrier-repair formulations. Address the dryness and sensitivity that most people actually notice, and the most cost-effective intervention for symptomatic skin.

Alpha hydroxy acids. Evidence for texture and pigmentation at appropriate concentrations.

A person spending on skin who bought sunscreen, a retinoid and a decent moisturiser, and no supplements, would have made better use of the money than the reverse.

A Defensible Approach

Non-negotiable and not a supplement: daily broad-spectrum sun protection, not smoking, and glycaemic control.

Topical core: a retinoid introduced gradually, a moisturiser suited to your barrier, and optionally topical vitamin C in the morning.

Reasonable supplements: collagen peptides 2.5 to 10 g daily with adequate vitamin C, if you want them and hold realistic expectations. Omega-3 for general reasons including barrier support. Vitamin D where status is low. Zinc where intake is low.

Specific situations: oral nicotinamide 500 mg twice daily is worth discussing with a clinician for anyone with a history of non-melanoma skin cancer. Polypodium leucotomos as an adjunct for high-exposure situations, never as a sunscreen substitute.

Skip: biotin unless status is genuinely low, high-dose vitamin E, proprietary beauty blends with a dozen ingredients at undisclosed doses, and anything marketed as an oral sunscreen, which does not exist.

Expectations. Skin interventions take 12 weeks minimum to show anything, since epidermal turnover and dermal remodelling operate on that timescale. Judging a product at four weeks is judging too early, and photographs in consistent lighting are more reliable than memory.

How to Read Skin Supplement Marketing

Three checks handle most of it.

What was measured, and by what? Instrumental measures of hydration, elasticity and wrinkle depth are meaningfully better than self-reported satisfaction. Studies reporting only participant questionnaires in an unblinded design tell you little.

Who funded it, and how many participants? Small industry-funded trials dominate this category. That does not make them wrong and it should shift how much weight they carry.

Is the comparison to a topical or to nothing? Almost every skin supplement is tested against placebo rather than against a retinoid, which means the relevant comparison, is this a better use of money than a proven topical, is never made.

Applied consistently, these leave collagen peptides as a reasonable optional purchase, oral nicotinamide as a specific clinical consideration, and most of the rest as optional at best.